Fidelity Investments
UTMD icon

Fidelity Investments’s Utah Medical Products UTMD Stock Holding History

Fidelity Investments’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Buy
18,062
+4,822
+36% +$304K ﹤0.01% 2831
2025
Q4 		$741K Buy
13,240
+473
+4% +$27.4K ﹤0.01% 2955
2025
Q3 		$804K Buy
12,767
+5,018
+65% +$297K ﹤0.01% 2870
2025
Q2 		$441K Buy
7,749
+4,531
+141% +$246K ﹤0.01% 3006
2025
Q1 		$180K Sell
3,218
-89,142
-97% -$5.34M ﹤0.01% 3288
2024
Q4 		$5.68M Sell
92,360
-176,463
-66% -$11.4M ﹤0.01% 2111
2024
Q3 		$18M Sell
268,823
-145,639
-35% -$9.89M ﹤0.01% 1743
2024
Q2 		$27.7M Buy
414,462
+21,417
+5% +$1.46M ﹤0.01% 1534
2024
Q1 		$27.9M Buy
393,045
+3,337
+0.9% +$250K ﹤0.01% 1542
2023
Q4 		$32.8M Sell
389,708
-123
-0% -$10.2K ﹤0.01% 1450
2023
Q3 		$33.5M Buy
389,831
+7,738
+2% +$714K ﹤0.01% 1394
2023
Q2 		$35.6M Buy
382,093
+35
+0% +$3.3K ﹤0.01% 1396
2023
Q1 		$36.2M Buy
382,058
+25
+0% +$2.3K ﹤0.01% 1373
2022
Q4 		$38.4M Buy
382,033
+597
+0.2% +$54.5K ﹤0.01% 1358
2022
Q3 		$32.5M Sell
381,436
-245
-0.1% -$21.6K ﹤0.01% 1419
2022
Q2 		$32.8M Sell
381,681
-31
-0% -$2.64K ﹤0.01% 1440
2022
Q1 		$34.3M Sell
381,712
-86,011
-18% -$7.91M ﹤0.01% 1552
2021
Q4 		$46.8M Sell
467,723
-29,140
-6% -$2.97M ﹤0.01% 1447
2021
Q3 		$46.1M Sell
496,863
-39,224
-7% -$3.46M ﹤0.01% 1448
2021
Q2 		$45.6M Sell
536,087
-9,888
-2% -$856K ﹤0.01% 1477
2021
Q1 		$47.3M Buy
545,975
+1,002
+0.2% +$88.1K ﹤0.01% 1432
2020
Q4 		$45.9M Sell
544,973
-1,498
-0.3% -$128K ﹤0.01% 1351
2020
Q3 		$43.6M Buy
546,471
+107
+0% +$8.88K ﹤0.01% 1245
2020
Q2 		$48.4M Buy
546,364
+112,808
+26% +$10.1M 0.01% 1180
2020
Q1 		$40.8M Sell
433,556
-2,342
-0.5% -$218K 0.01% 1111
2019
Q4 		$47M Sell
435,898
-14,400
-3% -$1.46M 0.01% 1237
2019
Q3 		$43.2M Sell
450,298
-60,465
-12% -$5.62M 0.01% 1228
2019
Q2 		$48.9M Buy
510,763
+22,508
+5% +$1.89M 0.01% 1228
2019
Q1 		$43.1M Buy
488,255
+11,248
+2% +$989K 0.01% 1274
2018
Q4 		$39.6M Sell
477,007
-1,849
-0.4% -$163K 0.01% 1242
2018
Q3 		$45.1M Sell
478,856
-40,283
-8% -$3.85M 0.01% 1324
2018
Q2 		$57.2M Sell
519,139
-32,389
-6% -$3.38M 0.01% 1219
2018
Q1 		$54.5M Buy
551,528
+30,439
+6% +$2.72M 0.01% 1257
2017
Q4 		$42.4M Buy
521,089
+13,802
+3% +$1.08M 0.01% 1373
2017
Q3 		$37.3M Buy
507,287
+15,310
+3% +$1.1M ﹤0.01% 1443
2017
Q2 		$35.6M Buy
491,977
+15,872
+3% +$1.04M ﹤0.01% 1443
2017
Q1 		$29.7M Buy
476,105
+2,384
+0.5% +$150K ﹤0.01% 1529
2016
Q4 		$34.5M Buy
473,721
+2,301
+0.5% +$150K ﹤0.01% 1461
2016
Q3 		$28.2M Buy
471,420
+531
+0.1% +$33.8K ﹤0.01% 1536
2016
Q2 		$29.7M Buy
470,889
+10,789
+2% +$696K ﹤0.01% 1497
2016
Q1 		$28.8M Buy
460,100
+3,615
+0.8% +$213K ﹤0.01% 1497
2015
Q4 		$26.7M Buy
456,485
+7,529
+2% +$427K ﹤0.01% 1542
2015
Q3 		$24.2M Buy
448,956
+15,720
+4% +$857K ﹤0.01% 1583
2015
Q2 		$25.8M Buy
433,236
+8,236
+2% +$464K ﹤0.01% 1629
2015
Q1 		$25.4M Hold
425,000
– – ﹤0.01% 1642
2014
Q4 		$25.5M Hold
425,000
– – ﹤0.01% 1629
2014
Q3 		$20.7M Hold
425,000
– – ﹤0.01% 1719
2014
Q2 		$21.9M Hold
425,000
– – ﹤0.01% 1756
2014
Q1 		$24.6M Hold
425,000
– – ﹤0.01% 1675
2013
Q4 		$24.3M Hold
425,000
– – ﹤0.01% 1631
2013
Q3 		$25.3M Sell
425,000
-13,418
-3% -$732K ﹤0.01% 1602
2013
Q2 		$23.8M Buy
+438,418
New +$20.6M ﹤0.01% 1578

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments's UTMD Position: Q1 2026 in Review

Fidelity Investments increased its Utah Medical Products (UTMD) stake by 36% in Q1 2026, buying an estimated $304K and bringing the position to 18,062 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2831.

Fidelity Investments first reported a position in UTMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $57.2M in Q2 2018. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Fidelity Investments held 18,062 shares of Utah Medical Products worth $1.12M as of Q1 2026.
  • Fidelity Investments bought 4,822 Utah Medical Products shares in Q1 2026, an estimated $304K.
  • Utah Medical Products made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2831 holding.
  • Fidelity Investments first reported a position in Utah Medical Products in Q2 2013 and has held it in 52 quarters since.
  • Fidelity Investments's Utah Medical Products position peaked at $57.2M in Q2 2018.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.